Risk of severe acute respiratory syndrome coronavirus 2 (<scp>SARS‐CoV</scp>‐2) transmission during bronchoscopy in the intensive care unit

Saha, Biplab K.; Chenna, Praveen

doi:10.1111/resp.14131

Cited by 6 publications

(5 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Border controls, restricting access and telemedicine can protect HCWs by removing the hazard from the workplace or remove proximity to SARS‐CoV‐2 110 . Procedures can be substituted to be less aerosol generating 130 by the use of spacers instead of nebulizers 120 and the use of disposable bronchoscopes 131 . The American College of Occupational and Environmental Medicine has recently published guidelines for procedures to be followed for routine spirometry.…”

Section: Policies and Practices To Prevent Covid‐19 Infection In Hcwsmentioning

confidence: 99%

“…110 Procedures can be substituted to be less aerosol generating 130 by the use of spacers instead of nebulizers 120 and the use of disposable bronchoscopes. 131 The American College of Occupational and Environmental Medicine has recently published guidelines for procedures to be followed for routine spirometry. These are based on the hierarchy of controls and recommend precautions to be used based on risk assessments.…”

Section: Policies and Practices To Prevent Covid-19 Infection In Hcwsmentioning

confidence: 99%

See 1 more Smart Citation

COVID‐19 infection and the broader impacts of the pandemic on healthcare workers

et al. 2022

View full text Add to dashboard Cite

The severe acute respiratory syndrome coronavirus (SARS‐CoV‐2) disease or COVID‐19 pandemic is associated with more than 230 million cases and has challenged healthcare systems globally. Many healthcare workers (HCWs) have acquired the infection, often through their workplace, with a significant number dying. The epidemiology of COVID‐19 infection in HCWs continues to be explored, with manifold exposure risks identified, leading to COVID‐19 being recognised as an occupational disease for HCWs. The physical illness due to COVID‐19 in HCWs is similar to the general population, with some HCWs experiencing a long‐term illness, which may impact their ability to return to work. HCWs have also been affected by the immense workplace and psychosocial disruption caused by the pandemic. The impacts on the psychological well‐being of HCWs globally have been profound, with high prevalence estimates for mental health symptoms, including emotional exhaustion. Globally, governments, healthcare organisations and employers have key responsibilities, including: to be better prepared for crises with comprehensive disaster response management plans, and to protect and preserve the health workforce from the physical and psychological impacts of the pandemic. While prioritising HCWs in vaccine rollouts globally has been critical, managing exposures and outbreaks occurring in healthcare settings remains challenging and continues to lead to substantial disruption to the health workforce. Safeguarding healthcare workforces during crises is critical as we move forward on the new path of ‘COVID normal’.

show abstract

Section: Policies and Practices To Prevent Covid‐19 Infection In Hcwsmentioning

confidence: 99%

Section: Policies and Practices To Prevent Covid-19 Infection In Hcwsmentioning

confidence: 99%

COVID‐19 infection and the broader impacts of the pandemic on healthcare workers

et al. 2022

View full text Add to dashboard Cite

show abstract

“…et al summarized data from seven cohort studies that assessed the risk of COVID-19 transmission among bronchoscopists and other healthcare workers in a total of 650 mechanically ventilated patients [ 23 ]. Sixty bronchoscopists were involved with an average of 16.8 exams each, and only two of them were infected with SARS-CoV-2, while none of the bedside nurses, respiratory therapists, or technicians were [ 23 ]. Therefore, when personal protective equipment is appropriately used, the risk appears to be lower than expected.…”

Section: Discussionmentioning

confidence: 99%

Diagnostic Role of Bronchoalveolar Lavage in Patients with Suspected SARS-CoV-2 Pneumonia and Negative Upper Respiratory Tract Swab: A Systematic Review and Meta-Analysis

Mei

Rota

Bonifazi

et al. 2022

JCM

View full text Add to dashboard Cite

The added role of bronchoalveolar lavage (BAL) in SARS-CoV-2 detection in hospitalized patients with suspected COVID-19 pneumonia and at least one negative nasopharyngeal swab (NPS) has yet to be definitively established. We aimed to provide a systematic review and meta-analysis to summarize data from the literature on the diagnostic yield of BAL in this context. We searched Medline and Embase for all studies reporting outcomes of interest published up to October 2021. Two authors reviewed all titles/abstracts and retrieved the selected full texts according to predefined selection criteria. The summary estimate was derived using the random-effects model. Thirteen original studies, involving 868 patients, were included. The summary estimate of proportions of SARS-CoV-2 positivity in BAL fluid in patients with at least one previous negative NPS was 20% (95% confidence interval [CI]; 11–30%). Moreover, microbiological tests of BAL fluid led to the identification of other pathogens, mainly bacteria, in up to two-thirds of cases. BAL plays a crucial role in the diagnostic work-up of patients with clinical suspicion of COVID-19 and previous negative NPS, as it allowed to detect the infection in a significant proportion of subjects, who would have been otherwise misclassified, with relevant implications in the prevention of disease spread, especially in hospital settings.

show abstract

“…However, it has not been deeply investigated since the recent commentary by Saha B.K. and Chenna P. [48]. Indeed, they have summarized seven cohort studies that assessed the risk of COVID-19 transmission during bronchoscopy among bronchoscopists and other healthcare workers in mechanically ventilated patients.…”

Section: Future Evidence and Perspectives: "The New Routine"mentioning

confidence: 99%

“…Overall, these studies strongly support the use of bronchoscopy in COVID-19 patients whenever clinically indicated. Indeed, when appropriate infection control precautions are taken and healthcare workers use appropriate personal protective equipment (PPE), the risk of infection appears to be very low [48].…”

Section: Future Evidence and Perspectives: "The New Routine"mentioning

confidence: 99%

The Role of Bronchoscopy in the Diagnosis and Management of Patients with SARS-Cov-2 Infection

et al. 2021

View full text Add to dashboard Cite

Bronchoscopy has several major diagnostic and therapeutic indications in pulmonology. However, it is an aerosol-generating procedure that places healthcare providers at an increased risk of infection. Now more than ever, during the spread of the coronavirus disease 2019 (COVID-19) pandemic, the infectious risk during bronchoscopy is significantly raised, and for this reason its role in diagnostic management is debated. In this review, we summarized current evidence regarding the indications for bronchoscopy and the measures that should be applied to decrease risk exposure. Indeed, seeing the long-lasting period of the pandemic, resuming standard of care for all patients is required.

show abstract

Risk of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) transmission during bronchoscopy in the intensive care unit

Cited by 6 publications

References 7 publications

COVID‐19 infection and the broader impacts of the pandemic on healthcare workers

COVID‐19 infection and the broader impacts of the pandemic on healthcare workers

Diagnostic Role of Bronchoalveolar Lavage in Patients with Suspected SARS-CoV-2 Pneumonia and Negative Upper Respiratory Tract Swab: A Systematic Review and Meta-Analysis

The Role of Bronchoscopy in the Diagnosis and Management of Patients with SARS-Cov-2 Infection

Contact Info

Product

Resources

About